School of Medicine

The first participants have been enrolled in an international clinical trial, led by WashU Medicine, aimed at preventing Alzheimer’s disease in young adults at high risk of the disease.

Graham A. Colditz, MD, DrPH, the Niess-Gain Professor of Surgery and director of the Public Health Sciences Division in the Department of Surgery at WashU Medicine, has been awarded the Brinker Award for Scientific Distinction in Population Science.

The National Cancer Institute, part of the National Institutes of Health (NIH), has awarded Aimilia Gastounioti, an assistant professor at WashU Medicine, a five-year $3 million grant to improve breast cancer risk assessments for Black women.

Researchers at WashU Medicine have received two grants totaling more than $10 million from the National Institutes of Health (NIH) to study the human body’s resident viruses, those not known to be associated with disease.

Three WashU faculty members have been awarded a $3 million research grant from the National Institute of Mental Health to address economic and structural barriers associated with access and use of an oral medication to prevent HIV infection.

Juliane Bubeck Wardenburg, MD, PhD, at WashU Medicine, brings empathy and compassion to families with children in critical care. She also is working on strategies to prevent staph infections in infants.

WashU Medicine researchers have received two large grants from the NIH renewing funding for the Human Pangenome Reference Sequencing Project.

People prescribed the popular GLP-1 weight-loss drugs such as Ozempic and Mounjaro may experience benefits such as increased cognitive and behavioral health, according to scientists at WashU Medicine and the Veterans Affairs St. Louis Health Care System. But users may also face increased risks for pancreatitis and kidney conditions, among other illnesses.

A new study led by WashU Medicine researchers has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals.

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.